Free shipping on all orders over $ 500

Anisomycin

Cat. No. M5145
Anisomycin Structure
Synonym:

Flagecidin;Wuningmeisu C

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 45  USD45 In stock
10mg USD 40  USD40 In stock
50mg USD 90  USD90 In stock
100mg USD 160  USD160 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Anisomycin is a pyrrolidine antibiotic, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin (3 μM) decreases protein synthesis in MDA16 and MDA-MB-468 cells, and reduces colony formation by MDA-MB-468 cells. Anisomycin causes an increase in the number of apoptotic cells in MDA-MB-468 cultures, but not in MDA16 cultures. In U251 and U87 cells, anisomycin (0.01-8 μM) inhibits the cell growth in time- and concentration-dependent manners with the IC50 (48 h) values of 0.233 and 0.192 μmol/L, respectively. Anisomycin inhibits EAC cell proliferation in concentration-dependent manner.

Peritumoral administration of anisomycin (5 mg/kg) significantly suppresses Ehrlich ascites carcinoma (EAC) growth resulting in the survival of approximately 60% of the mice 90 days after EAC inoculation.

Chemical Information
Molecular Weight 265.3
Formula C14H19NO4
CAS Number 22862-76-6
Solubility (25°C) DMSO 40 mg/mL
Ethanol 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Monaghan D, et al. Biochem Biophys Res Commun. Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues.

[2] You P, et al. Oncol Rep. In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma.

Related JNK Products
JIP-1(153-163)

JIP-1(153-163) (TI-JIP) is a peptide inhibitor of c-JNK, based on residues 153-163 of JNK-interacting protein-1 (JIP-1) (Modifications: Phe-11 = C-terminal amide).

JNK3 inhibitor-5

JNK3 inhibitor-5 is a potent and selective JNK3 inhibitor with an IC50 of 0.379 nM.

JNK-1-IN-1

JNK-1-IN-1 is a JNK-1 inhibitor.

JNK2-IN-1

JNK2-IN-1 is a JNK2 inhibitor (Kds: 79.2 μM).

JNK-1-IN-2

JNK-1-IN-2 is a JNK-1 inhibitor (IC50: 33.5 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: Anisomycin, Flagecidin;Wuningmeisu C supplier, JNK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.